Search Results

this disease, patients need careful consideration of treatment choice given the risk of potential toxicities from treatment and potential benefits. Surgery Partial hepatectomy is a potentially curative therapy for patients with a solitary tumor of

performance status, and quick wound healing, which allowed her to receive chemotherapy within 4 weeks of the esophageal surgery. In an alternate scenario, if this patient had only undergone superficial parotidectomy, she would have been treated as stage IV

newly diagnosed patients, postoperative therapy with nivolumab after preoperative chemoradiation and surgery in patients who have achieved R0 resections but have residual disease is a category 1 recommendation. For the first-line treatment of advanced

validated tools ( Table 1 ). Multiple studies have found that the CGA is more sensitive than performance status in determining functional impairment and risks associated with chemotherapy or surgery. 5 The CGA can uncover age-related issues in up to 50% of

detect and diagnose early-stage cancers, identify metastases noninvasively, and guide tumor removal during surgery. For image-guided surgery, the use of targeted nanoparticles to identify lesions has been an active area of investigation. In general

, accounting for 25% of malignant tumors in the major salivary glands and 50% in the minor glands. 2 The natural disease process is characterized by prolonged progression and multiple recurrences. 3 , 4 Surgery has been considered the most important treatment

Gynecologic Oncology Group study . J Clin Oncol 2003 ; 21 : 3194 – 3200 . 4. Hoskins WJ McGuire WP Brady MF . The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual

squamous epithelial cells (original magnification, ×20). At his follow-up visit 5 months after the surgery, the patient continued to have persistent headaches and peripheral vision loss, but they were milder than the initial symptoms reported before surgery

“Photodynamic therapy (PDT) is not just a palliative treatment,” declared Patrick Ross, Jr, MD, PhD, Director, Division of Thoracic Surgery, The Ohio State University (OSU), Columbus, Ohio. “The real bang for the buck with PDT has got to be

untreated and most will die of prostate cancer. 2 The argument for postoperative radiotherapy (RT) is predicated on the assumption that some patients may have residual local disease of a potentially lethal phenotype after surgery and that the delivery of